- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
IOLCP reported strong Q3 FY26 results: PBT surged 39% YoY to ₹38.8 Cr, with revenue up 10.9% to ₹580.4 Cr. Pharma segment revenue grew 18% and EBIT 32%, while Chemicals EBIT rose 37%. Focus on regulated markets & R&D for sustained growth.
All announcements from IOL Chemicals and Pharmaceuticals Limited